MedPath

Irsogladine

Generic Name
Irsogladine
Drug Type
Small Molecule
Chemical Formula
C9H7Cl2N5
CAS Number
57381-26-7
Unique Ingredient Identifier
QBX79NZC1D

Overview

Irsogladine is under investigation in clinical trial NCT02581696 (The Drug-drug Interaction and Safety of Lafutidine and Irsogladine Maleate in Healthy Adult Volunteers).

Indication

⑴用于治疗胃溃疡;⑵用于改善急性胃炎和慢性胃炎急性发作期的胃粘膜病变(糜烂、出血、充血、水肿)。

Associated Conditions

No associated conditions information available.

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
No FDA approvals found for this drug.

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
Irsogladine Maleate Tablets
国药准字HJ20150259
化学药品
片剂
8/13/2020
Irsogladine Maleate Tablets
国药准字H20050944
化学药品
片剂
6/1/2020
Irsogladine Maleate Tablets
国药准字H10980047
化学药品
片剂
9/23/2019
Irsogladine Maleate Tablets
国药准字H20020374
化学药品
片剂
6/1/2020
Irsogladine Maleate Tablets
国药准字H19990064
化学药品
片剂
9/9/2024
Irsogladine Maleate Tablets
国药准字H10980048
化学药品
片剂
5/11/2024
Irsogladine Maleate Tablets
国药准字HJ20150260
化学药品
片剂
8/13/2020

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product
ARTG ID
Sponsor
Registration Type
Status
Registration Date
No TGA approvals found for this drug.

Help Us Improve

Your feedback helps us provide better drug information and insights.

© Copyright 2025. All Rights Reserved by MedPath